References
- Barker RA, Anderson JR, Meyer P, et al. Microangiopathy of the brain and retina with hearing loss in a 50 year old woman: extending the spectrum of Susac's syndrome. J Neurol Neurosurg Psychiatry 1999;66:641–3.
- Mateen FJ, Zubkov AY, Muralidharan R, et al. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol 2012;19:800–11.
- Hardy TA, O'Brien B, Gerbis N, et al. Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment. J Neurol Neurosurg Psychiatry 2015;86:582–4.
- Dorr J, Krautwald S, Wildemann B, et al. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol 2013;9:307–16.
- Aubart-Cohen F, Klein I, Alexandra JF, et al. Long-term outcome in Susac syndrome. Medicine (Baltimore) 2007;86:93–102.
- Rennebohm RM, Egan RA, Susac JO. Treatment of Susac's syndrome. Curr Treat Options Neurol 2008;10:67–74.
- Egan RA, Hills WL, Susac JO. Gass plaques and fluorescein leakage in Susac syndrome. J Neurol Sci 2010;299:97–100.
- Klufas MA, Dinkin MJ, Bhaleeya SD, et al. Ultra-widefield fluorescein angiography reveals retinal phlebitis in Susac's syndrome. Ophthalmic Surg Lasers Imaging Retina 2014;45:335–7.
- Ringelstein M, Albrecht P, Kleffner I, et al. Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography. Neurology 2015;85:610–8.
- Mallam B, Damato EM, Scolding NJ, et al. Serial retinal fluorescein angiography and immune therapy in Susac's syndrome. J Neurol Sci 2009;285:230–4.
- Rennebohm R, Susac JO, Egan RA, et al. Susac's syndrome – update. J Neurol Sci 2010;299:86–91.
- Zhovtis Ryerson L, Kister I, Snuderl M, et al. Incomplete Susac syndrome exacerbated after natalizumab. Neurol Neuroimmunol Neuroinflamm 2015;2:e151.
- Jarius S, Kleffner I, Dorr JM, et al. Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study. J Neuroinflamm 2014;11:46.
- Rennebohm RM, Lubow M, Rusin J, et al. Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model. Pediatr Rheumatol 2008;6:3.
- Prakash G, Jain S, Gupta M, et al. Susac's syndrome: first from India and youngest in the world. Indian J Ophthalmol 2013;61:772–3.
- Brainin M, Steiner M. Acute stroke units in Austria are being set up on a national level following evidence-based recommendations and structural quality criteria. Cerebrovasc Dis 2003;15:29–32.
- Hofmarcher MM, Quentin W. Austria: health system review. Health Syst Transit 2013;15:1–292.
- Schoenberg BS. Calculating confidence intervals for rates and ratios. Neuroepidemiology 1983;2:257–65.
- www.statistik.at. [ accessed 26 October 2015].
- Bennett DA, Brayne C, Feigin VL, et al. Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology. Neurology 2015;85:821–8.
- Petty GW, Matteson EL, Younge BR, et al. Recurrence of Susac syndrome (retinocochleocerebral vasculopathy) after remission of 18 years. Mayo Clin Proc 2001;76:958–60.
- Feresiadou A, Eriksson U, Larsen HC, et al. Recurrence of Susac syndrome following 23 years of remission. Case Rep Neurol 2014;6:171–5.
- Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010;9:520–32.
- Horga A, Raja Rayan DL, Matthews E, et al. Prevalence study of genetically defined skeletal muscle channelopathies in England. Neurology 2013;80:1472–5.
- Aboul-Enein F, Seifert-Held T, Mader S, et al. Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people. PLoS One 2013;8:e79649.
- Baumhackl U, Eibl G, Ganzinger U, et al. Prevalence of multiple sclerosis in Austria. Results of a nationwide survey. Neuroepidemiology 2002;21:226–34.
- Wittie M, Nelson LM, Usher S, et al. Utility of capture-recapture methodology to assess completeness of amyotrophic lateral sclerosis case ascertainment. Neuroepidemiology 2013;40:133–41.
- Laird PW, Newman NJ, Yeh S. Exacerbation of Susac syndrome retinopathy by interferon Beta-1a. Arch Ophthalmol 2012;130:804–6.